Ignite Creation Date:
2025-12-24 @ 2:40 PM
Ignite Modification Date:
2025-12-27 @ 2:30 AM
Study NCT ID:
NCT03419559
Status:
WITHDRAWN
Last Update Posted:
2019-04-16
First Post:
2018-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer
Sponsor:
Iovance Biotherapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-14
First Submit QC Date:
None
Study First Post Date:
2018-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-11
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL